click below
click below
Normal Size Small Size show me how
NS drugs--pharm
| Question | Answer |
|---|---|
| Bethanechol | muscarinic agonist cholinesterase prototype treatment of postpartum and post-operative non-obstructive urinary retention |
| acetylcholine | muscarinic agonist cholinesterase |
| methacholine | muscarinic agonist cholinesterase |
| carbachol | muscarinic agonist cholinesterase mitotic agent (small pupils) for glaucoma |
| Pilocarpine | muscarinic agoinst natural alkaloid prototype treatment of glaucoma |
| muscarine | muscarinic agonist natural alkaloid considered a toxin--from mushrooms |
| atropine | muscarinic antagonist prototype natural alkaloid L-Hyoscyamine |
| scopalamine | muscarinic antagonist prototype L-Hyoscine |
| CNS compounds (Anti-Parkinsons) Muscarinic antagonists | benztropine trihexylphenidyl biperiden procyclidine |
| benztropine | CNS compound (Anti-Parkinsons) Muscarinic antagonists |
| trihexylphenidyl | CNS compound (Anti-Parkinsons) Muscarinic antagonists |
| biperiden | CNS compound (Anti-Parkinsons) Muscarinic antagonist |
| procyclidine | CNS compound (Anti-Parkinsons) Muscarinic antagonist |
| Muscarinic antagonists Urinary incontinence drugs | oxybutynin tolteridine |
| oxybutynin | Muscarinic antagonist Urinary incontinence drugs |
| tolteridine | Muscarinic antagonist Urinary incontinence drugs |
| Muscarinic antagonists Inhalants | Ipratropium Tiotropium |
| Ipratropium | Muscarinic antagonist; bronchodilator; used for cholinergic-mediated bronchospasm related to COPD; causes dry mouth |
| Tiotropium | Muscarinic antagonist; bronchodilator; significantly longer half-life; some selectivity for M3 |
| Methylscopolamine bromide | Muscarinic antagonist GI spasms |
| Homatropine methylbromide | Muscarinic antagonist GI spasms and IBS |
| Prothantheline | Muscarinic antagonist ulcer |
| Glycopyrrolate | Muscarinic antagonist anti-vagal with anesthesia |
| Receptor subtype selective muscarinic antagonists | pirenzepine (M1, M4 selective) acid-peptic disorders darifenacin (somewhat M3 selective) urinary incontinence |
| Tensilon test used to diagnose Myasthenia Gravis | Edrophonium |
| Pralidoxime (2-PAM) | treatment of organophosphate poisoning |
| Indirect muscarinic agonists treatment of glaucoma by targeting muscarinic receptors | Echothiophate diisopropyl fluorophosphate |
| Indirect muscarinic agonists treatment of Myasthenia Gravis by targeting nicotinic receptors (do not cross BBB) | neostigmine pyridostimine ambenonium |
| Indirect muscarinic agonists treatment of Alzheimer's | Physostigmine Tacrine Donepezil Galantamine |
| Indirect muscarinic agonists Bug poisons | Parathion malathion sevin chlorpyriphos |
| Indirect muscarinic agonists Human poisons | Sarin Soman VX (dermal LD50 ~784ug) |
| Main classes of Indirect muscarinic agonists | Quaternary amines carbamates Organophosphates |
| Indirect muscarinic agonists Quaternary amines | Edrophonium very short-acting |
| Indirect muscarinic agonists carbamates | neostigmine physostigmine intermediate to long-acting |
| Indirect muscarinic agonists organophosphates | diisopropyl fluorophosphate very long acting (so slow its irreversible) |
| Nicotinic blockers | acetylcholine succinylcholine pancuronium tubocurarine atracurium doxacurium |
| Nicotinic blocker prototype | tubocurarine |
| Steroid-based neuromuscular blockers | Pancuronium Pipecuronium Vecuronium Rocuronium |
| Nicotinic blocker that acts initially as a depolarizing agent, then it becomes a non-depolarizing agent | succinylcholine |
| most notable effect of alpha-1 | vasoconstriction |
| most notable effect of alpha-2 | lowers BP inhibition of sympathetic activity |
| most notable effect of beta-1 | stimulates the heart |
| most notable effect of beta-2 | bronchodilation blood vessel dilation |
| Dobutamine | beta-1 agonist increases cardiac output positive inotropic effect |
| Albuterol Terbutaline | short-acting beta-2 agonists used for asthma/COPD |
| Salmeterol Formoterol | long-acting beta-2 agonists used for asthma/COPD |
| Ritodrine | beta-2 agonist tocolytic (uterine relaxer) used to treat premature labor |
| Isoproterenol | prototypic non-selective beta agonist |
| Alpha-1 agonists nasal decongestants | Pseudoephedrine Phenylephrine Oxymetazoline |
| tetrahydrozoline | alpha-1 agonist gets red out of eyes by vasoconstriction |
| methoxamine | Alpha-1 agonist treats hypotension vasoconstrictor |
| Mephenteramine | Alpha-1 agonist direct and indirect acting (NE release) treats hypotension |
| Alpha-1 agonist direct and indirect acting (NE release) treats paroxysmal supraventricular tachycardia (vasocontriction causes reflex bradycardia) | Metaraminol |
| Midodrine | Alpha-1 agonist treats orthostatic hypotension |
| Norepinephrine (inject only) | Alpha-1 agonist treats severe acute hypotension |
| Alpha-1 agonist effects tried for weight loss, but causes cataracts | 2,4-dinitrophenol (DNP) |
| Alpha-1 agonist effects weight loss drugs | amphetamine, methamphetamine phentermine phendimetrazine, phenmetrazine diethylpropion phenylpropanolamine (Ayds) |
| Alpha-2 agonists used in treatment of BP used in treatment of drug withdrawal/addiction | clonidine guanabenz guanfacine |
| Tizanidine | Alpha-2 agonist muscle relaxer |
| Apraclonidine Brimonide | Alpha-2 agonists treatment of glaucoma--decrease aqueous humor production |
| false transmitter acts as alpha-2 agonist without much effect on alpha-1 receptor | Methyldopa |
| Phenoxybenzamine | Alpha-1 antagonist treatment for pheochromocytoma long-acting |
| Phentolamine | Alpha-1 antagonist treatment for pheochromocytoma effect 5-7 hrs |
| Alpha-1 antagonists vasodilators work on alpha-1>>>alpha-2 | Prazosin doxazosin terazosin tamsulosin |
| Prazosin | Alpha-1 antagonist prototype vasodilators work on alpha-1>>>alpha-2 |
| Yohimbine | alpha-2 antagonist used for sexual dysfunction |
| Beta antagonist prototype blocks beta-1 and beta-2 | propranolol |
| pindolol | Beta antagonist intrinsic sympathomimetic activity partial agonist effects at beta-2 |
| metoprolol | Beta antagonist selective for beta-1 (cardio-selective) |
| labetalol | Beta antagonist blocks beta receptors and alpha-1 ISA--partial agonist effects at beta-2 |
| acebutolol | Beta antagonist membrane stabalizing activity--may improve some cardiac arrhythmias |
| Cardio-selective beta blockers | acebutolol atenolol esmolol metoprolol |
| Non-selective beta blockers | labetalol nadolol pindolol propranolol timolol |
| beta blockers with ISA partial agonist effects at beta-2 | acebutolol labetalol pindolol |
| beta blocker with shortest half-life (10 minutes) | esmolol |